Snapshot from Aug 02, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Profound Medical Q2 2026 Results
Business earnings call

Profound Medical Q2 2026 Results

Analysis based on 8 articles · First reported Jul 16, 2026 · Last updated Jul 16, 2026

Sentiment
0
Attention
0
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is a routine earnings release schedule with no immediate market impact. The actual results on August 6 may affect Profound Medical's stock price depending on performance.

Medical Devices
Event Summary

Profound Medical announced it will release its second quarter 2026 financial results after market close on August 6, 2026, and host a conference call at 4:30 p.m. ET to discuss the results and business developments. The company is a commercial-stage medical device company specializing in interventional MRI procedures, with products TULSA-PRO for prostate ablation and Sonalleve for various treatments. Its technologies are approved in multiple global markets including the US, Europe, Canada, and others.

Key Actions
30 Profound Medical announce financial results
Entities Involved
stock
Profound Medical
Profound Medical is the subject of the event, announcing its Q2 2026 earnings release and conference call.
Importance 100.0 Sentiment 0.0
cnt
United States
Profound Medical's products are approved in the US market.
Importance 20.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
FDA has cleared TULSA-PRO and approved Sonalleve in the US.
Importance 20.0 Sentiment 0.0
exch
Nasdaq
Profound Medical is listed on Nasdaq under ticker PROF.
Importance 10.0 Sentiment 0.0
cnt
Canada
Profound Medical is headquartered in Canada and its products are cleared there.
Importance 10.0 Sentiment 0.0
loc
Europe
Profound Medical's products are cleared in Europe.
Importance 10.0 Sentiment 0.0
exch
Toronto Stock Exchange
Profound Medical is listed on TSX under ticker PRN.
Importance 10.0 Sentiment 0.0
cnt
Saudi Arabia
Profound Medical's products are cleared in Saudi Arabia.
Importance 5.0 Sentiment 0.0
cnt
Australia
Profound Medical's products are cleared in Australia.
Importance 5.0 Sentiment 0.0
cnt
United Arab Emirates
Profound Medical's products are cleared in the UAE.
Importance 5.0 Sentiment 0.0
cnt
India
Profound Medical's products are cleared in India.
Importance 5.0 Sentiment 0.0
cnt
New Zealand
Profound Medical's products are cleared in New Zealand.
Importance 5.0 Sentiment 0.0
cnt
China
Profound Medical's Sonalleve is cleared in China.
Importance 5.0 Sentiment 0.0
Relationships
United States related ↔ United States — Food and Drug Administration
United States related ↔ Nasdaq
United States strained-ally ↔ Canada The United States has severely strained its historically close relationship with Canada by imposing sweeping tariffs and
United States related ↔ Toronto Stock Exchange
United States security partner ↔ Saudi Arabia The United States views Saudi Arabia as a cornerstone of its Middle East security architecture, providing massive arms p
United States related ↔ Australia
United States ally ↔ United Arab Emirates The United States views the United Arab Emirates as a critical strategic and military partner in the Gulf, providing bil
United States — Food and Drug Administration related ↔ Canada
United States — Food and Drug Administration related ↔ Australia
United States — Food and Drug Administration related ↔ United Arab Emirates
Nasdaq related ↔ Toronto Stock Exchange
Canada related ↔ Toronto Stock Exchange
Canada related ↔ Saudi Arabia
Canada related ↔ Australia
Canada related ↔ United Arab Emirates
+ 3 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.